##gff-version 3
Q9P0V3	UniProtKB	Chain	1	963	.	.	.	ID=PRO_0000274574;Note=SH3 domain-binding protein 4	
Q9P0V3	UniProtKB	Domain	55	114	.	.	.	Note=SH3 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00192	
Q9P0V3	UniProtKB	Domain	317	454	.	.	.	Note=ZU5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00485	
Q9P0V3	UniProtKB	Domain	654	724	.	.	.	Note=SH3 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00192	
Q9P0V3	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:18691976;Dbxref=PMID:18691976	
Q9P0V3	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q9P0V3	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q921I6	
Q9P0V3	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:23186163;Dbxref=PMID:23186163	
Q9P0V3	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569	
Q9P0V3	UniProtKB	Modified residue	637	637	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:20068231,ECO:0007744|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q9P0V3	UniProtKB	Alternative sequence	515	925	.	.	.	ID=VSP_022823;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9303539;Dbxref=PMID:9303539	
Q9P0V3	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_030330;Note=M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16325581;Dbxref=dbSNP:rs3731644,PMID:16325581	
Q9P0V3	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_030331;Note=A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16325581;Dbxref=dbSNP:rs3731646,PMID:16325581	
Q9P0V3	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Loss of function. Loss of targeting to the clathrin-coated pits and vesicles. Loss of interaction with DNM2%2C RRAGB and RRAGC. No effect on localization to the plasma membrane. W->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16325581,ECO:0000269|PubMed:22575674;Dbxref=PMID:16325581,PMID:22575674	
Q9P0V3	UniProtKB	Sequence conflict	235	235	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305